Circulating platelet aggregates and plasma vitamin E levels in beta-thalassemic children. 1987

S Tawarat, and D Romcai, and N Chanarat, and P Kulapongs
Department of Clinical Microscopy, Chiang Mai University, Thailand.

UI MeSH Term Description Entries
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D013789 Thalassemia A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia. Thalassemias
D014810 Vitamin E A generic descriptor for all TOCOPHEROLS and TOCOTRIENOLS that exhibit ALPHA-TOCOPHEROL activity. By virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus, these compounds exhibit varying degree of antioxidant activity, depending on the site and number of methyl groups and the type of ISOPRENOIDS.

Related Publications

S Tawarat, and D Romcai, and N Chanarat, and P Kulapongs
May 1982, Annals of internal medicine,
S Tawarat, and D Romcai, and N Chanarat, and P Kulapongs
February 1978, Lancet (London, England),
S Tawarat, and D Romcai, and N Chanarat, and P Kulapongs
June 1984, Journal of pediatric gastroenterology and nutrition,
S Tawarat, and D Romcai, and N Chanarat, and P Kulapongs
January 1988, Child nephrology and urology,
S Tawarat, and D Romcai, and N Chanarat, and P Kulapongs
April 1978, Thrombosis and haemostasis,
S Tawarat, and D Romcai, and N Chanarat, and P Kulapongs
December 2008, Journal of clinical lipidology,
S Tawarat, and D Romcai, and N Chanarat, and P Kulapongs
January 1998, International ophthalmology,
S Tawarat, and D Romcai, and N Chanarat, and P Kulapongs
August 1996, Metabolism: clinical and experimental,
S Tawarat, and D Romcai, and N Chanarat, and P Kulapongs
October 1979, Klinische Wochenschrift,
S Tawarat, and D Romcai, and N Chanarat, and P Kulapongs
January 1993, Biomedical chromatography : BMC,
Copied contents to your clipboard!